ARTBIO’s Post

2nd Day at EANM in Vienna 📍 Interesting discussions and meetings about #microfluidics, #radiopharmaceuticals, #cyclotron and nuclear medicine in general...💬 Drop by our booth #203 (Hall X2), to find out more ! #molecularimaging #cancerresearch #PETimaging #theranostics #radiochemistry #radiosynthesis #nuclearmedicine

Yesterday we were delighted to participate in the Belgian EU Presidency Workshop: Securing Access to Radiopharmaceuticals for all European Patients during which Cristiana Gameiro was honored to present the innovative accelerators: pioneering technologies for advanced radioisotope production. This workshop featured very interesting presentations about radiopharmaceuticals' availability in Europe, regulatory framework and so inspiring patient testimonials treated by innovative radionuclide therapies. Is the Nuclear Medicine community in Europe ready for the future? Let's start the discussion in the comments! Belgian Presidency of the Council of the European Union 2024 #radiopharmaceuticals #radionuclide #cyclotron #EU2024BE

🔬 Behind the scenes, we play a vital role in the realm of nuclear medicine. ⚛️ With its half-life of 78.4 hours, Zr-89 has immense importance in diagnostic imaging and targeted therapy. It’s half-life makes it suitable for medical treatment and for distribution. ✈️📦 At our organization, we work tirelessly to ensure the safe and timely delivery of this crucial isotope, leaving no room for compromise when it comes to advancing patient care in the field of nuclear medicine. 🏥 #NuclearMedicine #Zirconium89 #IsotopeDelivery #PatientCare #PacerAirFreight #Zr89 #Timecriticalshipping #pharmalogistics #clinicaltrials #cancerresearch #cancertreatment

RADIOPHARMACEUTICALS – Their Role in the Paradigm Shift Toward Personalized Medicine (A Short Report from PharmaCircle) More than 40 million nuclear medicine procedures are being performed annually, making nuclear medicine -- or radiopharmaceuticals -- a noteworthy diagnostic and targeted treatment option in the world of personalized medicine. In this report, PharmaCircle explores where nuclear medicine is making the most impact, the product pipeline and venture capital investment activity. Learn more in The Weekly Brief at https://lnkd.in/eCbZrP9 #Nuclearmedicine #radiopharmaceuticals #personalizedmedicine #PharmaCircle 

#DidYouKnow in the 2010's, the emergence of radiotherapeutics using isotopes like Lu-177 marked a milestone shift in the nuclear medicine market, changing the importance of isotopes in healthcare? The radiotherapeutic market represented 20% of the total nuclear medicine market in 2019, up from 6% in 2013. Through continued investment and innovation, it is projected that radiotherapeutics will represent around 75% of the market by 2031, massively expanding the possibilities for personalized medical treatments!

Thank you to everyone who participated in our poll this week! Your engagement means a lot to us.  For this week's Nuclear Facts Unveiled with AtomVie Global Radiopharma (AtomVie), we would like to tackle a common myth or concern in the patient population. Myth: Nuclear medicine procedures such as PET scans involving radioactive agents will accumulate in the patient's body    Fact: Fear not! Because the amount of radiotracer used in nuclear medicine scans is extremely small, the patient’s radiation exposure is small. Nuclear medicine specialists use the ALARA principle (As Low As Reasonably Achievable) to carefully select the amount of radiopharmaceutical that will provide an accurate test with the least amount of radiation exposure to the patient. The actual dosage is determined by the patient’s body weight, the reason for the study and the body part being imaged. The targeted nature of radiopharmaceuticals allows them to be delivered mostly to the organ of interest while maintaining a low whole body radiation exposure. (source: https://lnkd.in/gKZvuFMn) Every Thursday for the next few weeks, we'll continue bringing you more myth busters right here on our LinkedIn page. Stay tuned! Drop a comment, share your thoughts, or suggest myths you'd like us to tackle. Let's make this a conversation! #AtomVieGlobalRadiopharma #NuclearFactsUnveiled #MythBusters #Radiopharmaceuticals #NuclearMedicine #DiagnosticImaging 

A #radiopharmaceutical agent used in nuclear medicine imaging procedures, particularly in myocardial perfusion imaging (#MPI) studies. Also known by its brand name, #Myoview, which is produced by the company ROTOP Pharmaka GmbH Radioisotope Centre POLATOM #LevalisPharmaDMCC #Levalis #Rotop #NuclearMedicine #Myocardial